Series
Surgical methods
Status
Published
Date
Number of report
039
Hernia repair
Ask the expert
The report presents a summary of the reimbursement situation for hernia repair in Europe. Indications include inguinal hernia, incisional hernia, umbilical hernia and femoral hernia. Use of synthetic and biological mesh devices is considered.
The only reimbursement within public / statutory health insurance systems is considered.
The report includes essential information about reimbursement, including:
- Brief country-specific overview of reimbursement system
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions on indications or scenarios for the use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- Austria
- Belgium
- Denmark
- England (UK)
- Finland
- France
- Germany
- Italy
- The Netherlands
- Norway
- Sweden
- Switzerland
It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.
Table of content is not available at this moment.
15
Oct 2021
The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on the use of new and existing health technologies, likely to have a significant impact on healthcare. In the third quarter of 2021, SHTG published only one report in relation to HeartFlow fractional flow reserve computerized tomography (FFRCT). Currently, the SHTG is working on assessments of technologies in the field of diabetes, digital health, surgical procedures, and other topics.
Read more22
Aug 2018
The report presents a summary of the reimbursement situation for hernia repair. Report includes analysis for inguinal hernia, incisional hernia, umbilical hernia and femoral hernia. Use of synthetic and biological mesh devices is considered in the report. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.
Read more